相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
46
- 英文名:
Recombinant Human BRCA1 protein
- 保质期:
12个月
- 供应商:
上海帛科
- 保存条件:
-20 to -80 °C
- 规格:
50μg、100ug 、1mg
| 货号 | BK-DB6500 | 用途 | 仅供科研研究实验 |
| 纯度 | >90% as determined by SDS-PAGE | 预测分子量 | 9.14 kDa |
| 表达宿主 | E.coli | 种属 | Homo sapiens (Human) |
蛋白构建: A DNA sequence encoding the human BRCA1 (Gln19-Val83) was fused with His tag
制剂: Supplied as solution form in PBS pH 7.5 or lyophilized from PBS pH 7.5.
运输方式: In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
稳定性&储存: Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 2 to 8 °C for one week .Store at -20 to -80 °C for twelve months from the date of receipt.
复溶: Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.
分子别名: Breast cancer type 1 susceptibility protein,RING finger protein 53,RING-type E3 ubiquitin transferase BRCA1.
背景介绍: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator.
重组蛋白质的可溶性鉴定:
1. 将按上法诱导培养后收集的菌体重悬于裂解液 1 (Lysis buffer under native conditions )中,然后在-80 oC 低温冰箱中放置 10 min。
2. 冰中解冻。
3. 在冰浴上用超声破碎仪破菌 6 次, 每次 10 sec,间歇 10 sec,电压 200-300 V。
4. 10000g,4oC,离心 20min,取上清(为溶液 A), - 20 oC 保存; 另将沉淀用 同样裂解液 1 溶解(为溶液 B),同样 -20 oC 保存,供后继分析使用。
5. 将上述 A、B 溶液和诱导前后的细菌进行 SDS-PAGE 电泳, 考马斯亮蓝染色, 比较分析重组蛋白质的溶解性。如果诱导表达的蛋白质位于 A 溶液中, 则为可溶性蛋白;如果是在 B 溶液中,则为非可溶蛋白。
重组蛋白质的分离纯化:
1. 将菌体沉淀溶于适量裂解液 2(Lysis buffer under denaturing conditions )中,室温下搅拌和吹打沉淀,避免泡沫生成。
2. 10000g ,4 oC,离心 30 min,收集上清液。
3. 将 Ni-NTAAgarose 充填柱子,并连接于 Pharmarcia 低压液相层析系统,用 5 倍柱体积的裂解液 2 平衡 Ni-NTAAgarose,调节 A280 值至零线。
4. 将适量上清液上样到 Ni-NTAAgarose 柱子中, 并用 lysis buffer 冲洗至 A280 值低于 0.01。
5. 分别用 5 ~ 10 倍柱体积的清洗液 1 和清洗液 2(Washbuffer 1 and 2)清洗柱 子,直至 A280 值低于 0.01。
6. 用洗脱液(Elution buffer)洗脱重组蛋白质, 在 A280 值监测下,收集出现峰 线后含有重组蛋白的所有洗脱液。
表达载体在基因工程有以下几种元件:
(1)选择标志的编码序列;
(2)可控转录的启动子;
(3)转录调控序列(转录终止子,核糖体结合位点);
(4)一个多限制酶切位点接头;
(5)宿主体内自主复制的序列。
重组蛋白质的诱导表达:
1. 挑取转化有质粒的单菌落, 接种于 3ml 选择性 LB 液体培养基中, 37 oC,250 rpm/min 振摇培养过夜。
2. 次日将培养过夜的菌液 500 μl 再接种于 10ml(1:20)选择性 LB 液体培养基 中, 37 oC,250 rpm/min 振摇培养至光密度(OD600=0.6)时,取 1 ml 样本作 为诱导前标本, 10000g 离心 1min 收集菌体沉淀,-20 oC 冻存备用。
3. 加入 1 mol/L IPTG 于菌液中,使 IPTG 终浓度为 1 mM ,37 oC ,250 rpm/min 振摇培养 4 ~ 5 小时。取 1 ml 样本作为诱导后标本,同上法收集菌体沉淀, -20 oC 冻存备用。
4. 将诱导前后菌体沉淀用 20 ~ 40 μl PBS(pH= 8.0)重悬, 加入等体积的 2×SDS 上样缓冲液, 煮沸加热 5min,SDS 聚凝胶(SDS-PAGE)电泳分离 , 考马斯亮蓝染色 3 小时后,脱色观察结果。
5. 选取诱导成功的细菌克隆,扩大诱导规模,收集菌体沉淀,于- 20 oC 保存,准备做下一步分析及纯化。
公司出售的相关产品:
| 细胞增殖诱导蛋白5/肺癌相关蛋白10封闭多肽 | 磷酸二酯酶7抗体 |
| 重组人粒细胞-巨噬细胞集落刺激因子3蛋白 | phospho-c-Abl (Tyr276) Antibody Blocking Peptide |
| UD2蛋白封闭多肽 | KRI1 Antibody Blocking Peptide |
| 细胞周期末期促进复合蛋白APC1封闭多肽 | PSPN Antibody Blocking Peptide |
| NT5C3样蛋白封闭多肽 | TAOK3 Antibody Blocking Peptide |
| 重组小鼠白介素4蛋白 | SBF2 Antibody Blocking Peptide |
| 接触蛋白相关蛋白4封闭多肽 | PRNP Antibody Blocking Peptide |
| 胞嘧啶脱氨酶封闭多肽 | Kv1.2 Antibody Blocking Peptide |
| 精子发生相关蛋白15封闭多肽 | TMED4 Antibody Blocking Peptide |
| 重组人C反应蛋白 | phospho-P53 (Thr55) Antibody Blocking Peptide |
| 磷酸化热休克蛋白70封闭多肽 | DRD4 receptor Antibody Blocking Peptide |
| Av-Tag多肽 | KRR1 Antibody Blocking Peptide |
| 唾液酸结合性免疫球蛋白样凝集素11封闭多肽 | Recombinant Human BRCA1 proteinUCRC Antibody Blocking Peptide |
| CRIP1 Antibody Blocking Peptide | |
| 磷酸化高迁移率核小体结合蛋白1封闭多肽 | MSH2 Antibody Blocking Peptide |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Methods for Producing Recombinant Human Cellular Retinaldehyde-Binding Protein
The cellular retinaldehyde-binding protein (CRALBP) is expressed at high levels in vertebrate visual trssue, where it may serve to modulate the interaction of 11-cis -retinol with visual-cycle enzymes in the retinal pigment epithelium (RPE
Recombinant Protein Production in Yeasts
Recombinant protein production is a multibillion-dollar market. The development of a new product begins with the choice of a production host. While one single perfect host for every protein does not exist, several expression systems ranging
Recombinant Protein Expression in Nicotiana
Recombinant protein pharmaceuticals are now widely used in treatment of chronic diseases, and several recombinant protein subunit vaccines are approved for human and veterinary use. With growing demand for complex protein pharmaceuticals
技术资料暂无技术资料 索取技术资料









